Sodium Oxybate for the Treatment of Vigilance Impairment in Narcolepsy
- Conditions
- Narcolepsy10040998
- Registration Number
- NL-OMON30579
- Lead Sponsor
- Academisch Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 40
Inclusion Criteria
- Definite narcolepsy-cataplexy, according to international criteria [AASM 2005],
- Patients have to be treatment-naive and planning to start sodium oxybate or already using sodium oxybate and prepared to stop medication at least 14 days prior to study start
Exclusion Criteria
- Younger than 18 or older than 70 years
- Cognitive impairment due to neurological disorders other than sleep-wake disorders
- Use of other hypnotics or other sleep-wake active drugs
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method